Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Akiko Okada"'
Autor:
Hiroki Hamano, Chie Fukuda, Masahiko Takahata, Dai Sato, Yoshiharu Hiruma, Tomohiro Shimizu, Norimasa Iwasaki, Tomoka Hasegawa, Masahiro Ota, Shigeto Hiratsuka, Eisuke Tsuda, Akiko Okada, Ryo Fujita, Norio Amizuka
Publikováno v:
Bone. 116:172-180
The treatment of juvenile osteoporosis has not been established due to a lack of data regarding the efficacy and adverse effects of therapeutic agents. The possible adverse effects of the long-term use of antiresorptive therapies on skeletal growth i
Autor:
Chie Fukuda, Tsuyoshi Karibe, Yoshitaka Isumi, Tomomaya Yamamoto, Tomoka Hasegawa, Seiichiro Kumakura, Nana Takagi, Norio Amizuka, Eisuke Tsuda, Yoshiharu Hiruma, Masanori Koide, Akiko Okada, Shunsuke Uehara, Nobuyuki Udagawa
Publikováno v:
Bone. 155
Recent studies have established the idea that Siglec-15 is involved in osteoclast differentiation and/or function, and it is anticipated that therapies suppressing Siglec-15 function can be used to treat bone diseases such as osteoporosis. We have pr
Autor:
Akiko Okada, Dai Sato, Yoshiharu Hiruma, Chie Fukuda, Norio Amizuka, Masahiro Ota, Tomoka Hasegawa, Norimasa Iwasaki, Ryo Fujita, Eisuke Tsuda, Tomomaya Yamamoto, Masahiko Takahata
Publikováno v:
Bone. 135
Effective treatment of juvenile osteoporosis, which is frequently caused by glucocorticoid (GC) therapy, has not been established due to limited data regarding the efficacy and adverse effects of antiresorptive therapies on the growing skeleton. We p
Autor:
Chie Fukuda, Yoshiharu Hiruma, Noriko Kabasawa, Megumi Miyamoto, Eisuke Tsuda, Hiroyuki Hattori, Akiko Okada, Naoyuki Maeda
Publikováno v:
Bone. 53(1)
Sialic acid-binding immunoglobulin-like lectin 15 (Siglec-15) is a cell surface receptor for sialylated glycan ligands. Recent in vitro studies revealed upregulated Siglec-15 expression in differentiated osteoclasts and inhibition of osteoclast diffe